Goldman Sachs heads into the back half of July with the post-earnings dust settling — the stock has recovered to $1,085.56, the analyst consensus target has converged to $1,134, and the key question now is whether the price can hold above the pre-earnings level it briefly abandoned.
The week's dominant dynamic is a partial recovery from last week's sharp reversal. GS bounced 2.9% on Tuesday, clawing back ground after falling nearly 5% on the week. That puts the stock almost exactly where the mean analyst target now sits — $1,134 — a notable shift from the July 15 note, when the stock was trading above consensus at $1,140. The inversion has corrected itself, but only because the stock fell rather than because targets moved higher. The convergence is tidy but not reassuring: bulls need the stock to clear $1,134 and hold, while the holdouts at JP Morgan (target $955) and HSBC (upgraded to Hold from Reduce yesterday, target $995) act as a ceiling on how far conviction can stretch.
The Street's post-earnings re-rating wave is now largely complete, with one notable addition. HSBC's Saul Martinez upgraded GS to Hold from Reduce on July 21, lifting his target to $995 from $834 — a meaningful shift in direction but still well below the current price. BMO Capital trimmed to $1,150 from $1,190 on July 17, a modest pullback that suggests some caution about near-term catalysts after the initial target-raising burst. The bulls — Barclays at $1,245, Wells Fargo at $1,325, BofA at $1,300 — remain firmly in place. The consensus of 16 Holds and one Sell reflects a Street that is directionally constructive but reluctant to chase. Factor scores back up the earnings quality: EPS momentum ranks in the 96th percentile on a 30-day basis and the 91st on 90 days, with EPS surprise at the 88th percentile — the Q2 beat was not an outlier relative to GS's recent track record.
Positioning is genuinely undemanding, and that remains the clearest message from the data. Short interest has drifted marginally higher this week — up roughly 1.4% to 2.03% of free float — but this follows a 15% decline over the prior month, leaving the short book near its lightest level of the recent period. Borrowing costs are negligible at 0.33% and falling, down more than 20% on the week. Borrow availability is extraordinarily loose, with over 150 million shares available — effectively no constraint on new shorts even if sentiment soured. Options positioning is similarly calm: the put/call ratio of 0.85 sits fractionally below its 20-day average of 0.86, a z-score of -0.36 that signals no particular defensive hedging. None of the lending or options signals point to elevated anxiety. Closest peer MS also fell nearly 5% on the week, suggesting the softness in GS is sector-wide rather than idiosyncratic.
The one angle worth noting from institutional flows is BlackRock's continued addition of shares — 737,807 added through June 30, bringing its stake to 7.82% of the company. State Street also added modestly. These are index-manager flows rather than active conviction bets, but they underline that large passive allocators are not trimming despite the post-earnings volatility.
The next scheduled earnings date is October 13. Between now and then, the debate will centre on whether the capital markets activity that drove the Q2 beat — M&A advisory, equities trading — sustains through Q3, or whether the macro backdrop, flagged in every bear-case note, starts to bite. The PE multiple has compressed nearly 3 points over 30 days to 15x, a reset that removes some of the valuation stretch; the price-to-book at 2.77x remains the more watched metric for a firm of GS's profile. How that multiple moves between now and October will tell more about where conviction is actually settling than any single analyst note.
See the live data behind this article on ORTEX.
Open GS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
